AmerisourceBergen’s PharMEDium unit subpoenaed over syringe production

Drug wholesaler AmerisourceBergen laid out $2.5 billion to buy the PharMEDium sterile drug compounding pharmacy operation, believing it will be a growth driver. But so far, the operations have become a regulatory quagmire for the company, now resulting in a DOJ investigation and a gut-kick to its earnings.Original Article